跳至主要内容
临床试验/IRCT20160310026998N12
IRCT20160310026998N12招募中3 期

Assessment of the effect of memantine in the treatment of chemotherapy-induced peripheral neuropathy: double-blind randomized clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 no limit(—)
性别
All

入选标准

  • People with any malignancy who have had grade 2 or higher neuropathy following chemotherapy

排除标准

  • Patients with hypertension
  • Acute heart failure
  • type 1 & 2 diabetes mellitus
  • peripheral vascular disease
  • 285/5000Patients taking drugs (amantadine, ketamine, dextromethorphan, L-dopa; dopaminergic, anticholinergic agonists, barbiturates, neuroleptics, IMAO, antispasmodics, dantrolene or baclofen, phenytoinquinotine, cimetidine, ranitidine And warfarin)
  • People of reproductive ages, pregnancy and lactation
  • People taking other neuropathic medications such as gabapentin, pregabalin and dologestin
  • Patients with brain or leptomeningeal metastasis

研究者

相似试验